To investigate the immunomodulatory effects of treatment with Tα1 + PCDs in CD4+ and CD8+ T cells during HCMV infection, we evaluated the expression of CD2 and CD40L, as well as the production of TNFα, IFNγ and IL-2 using multiparametric cytometry. The gene discussed is CD4; the disease is cytomegalovirus infection.